Broksaterol
Изглед
Nazivi | |
---|---|
IUPAC naziv
1-(3-Bromo-5-izoksazolil)-2-(tert-butilamino)etanol
| |
Identifikacija | |
3D model (Jmol)
|
|
ChemSpider | |
ECHA InfoCard | 100.071.338 |
MeSH | Broxaterol |
| |
Svojstva | |
C9H15BrN2O2 | |
Molarna masa | 263,14 g·mol−1 |
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
Reference infokutije | |
Broksaterol je beta-adrenergički agonist.[3]
Reference
[уреди | уреди извор]- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ Nava S, Crotti P, Gurrieri G, Fracchia C, Rampulla C (1992). „Effect of a beta 2-agonist (broxaterol) on respiratory muscle strength and endurance in patients with COPD with irreversible airway obstruction”. Chest. 101 (1): 133—40. PMID 1345900. doi:10.1378/chest.101.1.133. Архивирано из оригинала 14. 04. 2013. г. Приступљено 20. 09. 2012.